Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 86.69% is 98% above its 5-year average of 43.87%, near the high end of its 5-year range (0.00%–100.00%).
2.87% above its 12-month average of 84.27%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 89.92%.
GROSS MARGIN
86.69%
GROSS MARGIN AVG TTM
84.27%
GROSS MARGIN AVG 3Y
40.10%
GROSS MARGIN AVG 5Y
43.87%
GROSS MARGIN AVG 10Y
47.47%
GROSS MARGIN AVG 15Y
31.91%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+2.87%
CURRENT VS 3Y AVG
+116.16%
CURRENT VS 5Y AVG
+97.59%
CURRENT VS 10Y AVG
+82.60%
CURRENT VS 15Y AVG
+171.68%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+110.39%
vs the sector median at left
Market Cap
$681.27M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
33.33%
Market Cap
$685.49M
Gross Margin
-16.57%
TTM Avg
15.14%
3Y Avg
17.91%
5Y Avg
27.64%
Market Cap
$673.41M
Gross Margin
78.85%
TTM Avg
82.67%
3Y Avg
82.58%
5Y Avg
83.02%
Market Cap
$691.79M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$693.19M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$693.61M
Gross Margin
79.28%
TTM Avg
89.64%
3Y Avg
94.82%
5Y Avg
-12.16%
Market Cap
$694.79M
Gross Margin
53.23%
TTM Avg
53.64%
3Y Avg
56.38%
5Y Avg
57.18%
Market Cap
$666.95M
Gross Margin
100.27%
TTM Avg
50.13%
3Y Avg
25.07%
5Y Avg
10.71%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Verastem, Inc. (VSTM) | $681.02M | 86.69% | 84.27% | 40.10% | 43.87% |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | 0.00% | 0.00% | 25.00% | 33.33% |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | -16.57% | 15.14% | 17.91% | 27.64% |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 78.85% | 82.67% | 82.58% | 83.02% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | 79.28% | 89.64% | 94.82% | -12.16% |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | 53.23% | 53.64% | 56.38% | 57.18% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 100.27% | 50.13% | 25.07% | 10.71% |
| Annexon, Inc. (ANNX)vs › | $660.29M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
86.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 89.92% |
| 2026-03-31 | 83.66% |
| 2025-12-31 | 83.51% |
| 2025-09-30 | 85.14% |
| 2025-06-30 | 79.13% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 100.00% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 97.63% |
| 2020-09-30 | 59.23% |
| 2020-06-30 | 81.77% |
| 2020-03-31 | 82.46% |
| 2019-12-31 | 79.98% |
| 2019-09-30 | 91.55% |
| 2019-06-30 | 75.48% |
| 2019-03-31 | 67.09% |
| 2018-12-31 | 90.41% |
| 2018-09-30 | 99.48% |
| 2018-06-30 | 100.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
